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The expanded-spectrum -lactamase (ESBL) gene blaVEB-1, identified worldwide in Enterobacteriaceae and
Pseudomonas aeruginosa, is associated with either class 1 integrons or repeated elements. We report here the
first association of blaVEB-1a with the insertion sequence ISCR2 in six Acinetobacter species isolates recovered
from Argentina. That genetic structure was likely at the origin of the mobilization of this ESBL gene.
Among the different Ambler class A expanded-spectrum
-lactamase (ESBL) genes, the blaVEB-1 gene is considered to
be an emerging one since its presence has been detected in
many gram-negative organisms from different parts of the
world during the last decade (14, 25). It has been identified in
Enterobacteriaceae and Pseudomonas aeruginosa in many coun-
tries, such as France, Spain, Algeria, Turkey, Canada, Korea,
and Thailand (1, 2, 8, 23, 29). In addition, P. aeruginosa isolates
producing the VEB-1a variant (differing from VEB-1 by just a
single amino acid located in the leader peptide of the prema-
ture protein) have been found in Kuwait and India (3, 24).
VEB-1-producing Acinetobacter baumannii strains have been
identified in France, having disseminated on a nationwide scale
(13, 20).
The blaVEB-1 gene is often part of a gene cassette located in
class 1 integrons. In A. baumannii strain AYE from France, the
corresponding class 1 integron was itself part of an 86-kb re-
sistance island, the largest identified so far (7). However, in
some cases, the blaVEB-1 and blaVEB-1a genes have not been
identified in the form of gene cassettes, being associated with
peculiar genetic structures called repeated elements (Re) in P.
aeruginosa and Enterobacteriaceae (3, 12, 22).
From 2002 to 2004, several Acinetobacter isolates producing
the ESBL VEB-1a were recovered from different cities in Ar-
gentina (16). Six VEB-1a-positive isolates were retained: four
A. baumannii isolates, one Acinetobacter johnsonii isolate, and
one Acinetobacter genomospecies 10 isolate (17). Five of them
were shown previously to produce the narrow-spectrum -lac-
tamase SCO-1 (17). All six isolates are resistant to all -lac-
tams except carbapenems, with the exception of Acinetobacter
genomospecies 10, which coproduces the carbapenem-hydro-
lyzing oxacillinase OXA-58 and is resistant to imipenem (17).
Preliminary experiments performed by PCR mapping using
corresponding primers (3) showed that the blaVEB-1a gene is
neither part of a class 1 integron nor associated with Re ele-
ments in those isolates. Accordingly, we have examined the
genetic context of the blaVEB-1a gene in those six isolates in
order to predict its acquisition mechanism.
First, cloning experiments were performed using DNA from
a whole-cell preparation of one of the isolates, A. johnsonii
isolate 7037, and pBK-CMV as a cloning vector as described
previously (17). BamHI-restricted DNA fragments of A. johnsonii
7037 were ligated into a BamHI-digested plasmid and transferred
into Escherichia coli DH10B by electroporation as described
previously (18). Selection of recombinant clones was per-
formed using Trypticase soy agar plates containing 100 g of
amoxicillin (amoxicilline) and 30 g of kanamycin per ml.
Recombinant plasmid p7037B1, expressing an ESBL pheno-
type, was retained for further analysis. Sequencing of the
3,630-bp insert in p7037B1 identified the blaVEB-1a gene (Fig.
1). Upstream of blaVEB-1a, sequences corresponding to inser-
tion sequence ISCR2 (formerly designated the CR2 element)
were identified. In fact, the ISCR2 right-end extremity defined
as oriIS was located 223 bp upstream of blaVEB-1a, those 223 bp
including the GTTAGCG sequence usually defining the core
site of the blaVEB-1a gene cassette when blaVEB-1a is present in
class 1 integrons. Downstream of blaVEB-1a, a truncated copy of
ISCR2 (ISCR2) was present, the corresponding tnpA trans-
posase gene being truncated at its 5 extremity, resulting in a
protein lacking 119 of its 497 amino acids at the N-terminal
extremity. ISCR2 belongs to the ISCR family, which currently
includes 20 members, all presenting some similarities to IS91-
like insertion sequences (http://www.cardiff.ac.uk/medic/aboutus
/departments/medicalmicrobiology/genetics/iscr/iscr_elements
.html). The ISCR2 transposase shares less than 57% amino acid
identity with all other ISCR transposases. ISCRs are peculiar
since they do not possess inverted repeats, do not generate target
site duplications upon transposition, and transpose through a
process called rolling-circle transposition (28, 29).
The downstream 1,170-bp fragment separating the blaVEB-1a
gene from the ISCR2 element contained two open reading
* Corresponding author. Mailing address: Service de Bacte´riologie-
Virologie, Hoˆpital de Biceˆtre, 78 rue du Ge´ne´ral Leclerc, 94275 Le
Kremlin-Biceˆtre Cedex, France. Phone: 33-1-45-21-36-32. Fax: 33-1-
45-21-63-40. E-mail: nordmann.patrice@bct.aphp.fr.
 Published ahead of print on 24 August 2009.
4940
 o
n
 February 24, 2014 by Cardiff Univ
http://aac.asm
.org/
D
ow
nloaded from
 
frames (ORFs), in addition to the entire 59-bp sequence de-
fining the blaVEB-1a gene cassette when blaVEB-1a is integron
borne. One ORF corresponded to a 92-amino-acid putative
protein of unknown function, and the second corresponded to
a 103-amino-acid protein showing homology to helix-turn-helix
XRE family transcriptional regulators (Fig. 1). The latter pro-
tein shared 84% amino acid identity with a protein identified
by analysis of the genome of Psychroflexus torquis ATCC
700755 (GenBank accession number ZP_01253739).
We subsequently investigated the five other isolates of our
collection for the ISCR2-blaVEB-1a association. PCR assays
performed using blaVEB-1-specific primers (27) in combination
with ISCR2-specific primer ISCR2A (5-AAGAATTTCTCCA
ATGCGGG-3) or ISCR2B (5-GCGGCTCCTTTTCCGACA
AC-3) showed that in all isolates the blaVEB-1a gene was
bracketed by the ISCR2 elements, as found in isolate 7037.
Attempts to identify plasmids by using the Kieser technique
(10) permitted visualization of several plasmids in all the
blaVEB-1a-positive isolates. However, subsequent Southern hy-
bridization performed with a probe specific for blaVEB-1a indi-
cated that this ESBL gene was very likely chromosomally lo-
cated in all the isolates tested since a single hybridization signal
corresponding only to the chromosomal band was obtained
(data not shown). This result is in accordance with the results
of electrotransformation assays, performed as described previ-
ously (17), that did not allow the transfer of any -lactam
resistance marker into an A. baumannii recipient strain.
The finding of two copies of the ISCR2 element (including
one truncated copy) at the extremities of blaVEB-1a strongly
suggests that ISCR2 was at the origin of the gene’s mobiliza-
tion. According to the hypotheses raised by Toleman et al.
(28), it is very likely that an intact ISCR2 copy originally mo-
bilized blaVEB-1a by a rolling-circle transposition process and
that a secondary process of homologous recombination be-
tween two ISCR2 copies led to the observed structure. To
confirm the hypothesis that such recombination events may
occur, we performed a PCR assay using blaVEB-1a-specific out-
ward primers VEB-inv1 (5-CAGTTTGAGCATTTGAATAC
AC-3) and VEB-inv2 (5-AGCGTATTTGTTGCAGAGTC
C-3). Using DNA samples from all VEB-1a-positive isolates
as templates, a ca. 2,900-bp amplicon from each isolate was
obtained. Sequencing identified a structure encompassing the
blaVEB-1a gene and the corresponding downstream sequences,
together with the downstream ISCR2 truncated element.
However, the sequence of the upstream, intact ISCR2 copy was
not included in that amplicon. Therefore, homologous recom-
FIG. 1. Nucleotide sequence of a 3,630-bp BamHI fragment of recombinant plasmid p7037B1 containing the blaVEB-1a gene. The deduced
amino acid sequence is designated in single-letter code below the nucleotide sequence. The transcription orientations of the ORFs are indicated
by horizontal arrows (orf is the unknown gene, and xre is the gene encoding a putative transcriptional regulator). The right-end boundary of ISCR2,
defined as oriIS, is shaded. The putative promoter sequences of the blaVEB-1a gene, consisting of the 35 and 10 regions, are boxed. The tnpA
truncated transposase gene of ISCR2 is indicated. The stars indicate stop codons. The vertical arrows indicate the boundaries of the blaVEB-1a gene
cassette as found in class 1 integrons (with the core site sequence in bold) and also the location where ISCR2 is identified. The BamHI sites of
the cloned fragment are underlined.
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bination may have been at the source of the mobilization of the
blaVEB-1a gene in its present genetic context. Further studies
will be conducted to explore the possible role of the ISCR2
transposase in that recombination process, with regard to the
fact that the ISCR transposases were initially thought to be
recombinases (15).
The genetic structures involved in the mobilization process
for resistance genes often play an additional role in the genes’
expression by providing promoter sequences, as demonstrated
previously for many IS elements and class 1 integrons (11, 21)
and in particular for ISCR1 and ISCR4 (19, 27). In the ISCR2-
blaVEB-1a configuration in evidence here, no obvious feature
indicates a possible role of ISCR2 in blaVEB-1a expression.
Indeed, the distance separating the oriIS extremity of ISCR2
from the blaVEB-1a start codon is quite long and no putative
promoter is found in silico inside the ISCR2 sequence. In
contrast, a precise analysis of the sequences separating ISCR2
from the blaVEB-1a gene revealed putative promoter sequences
made of a 35 motif (TTGTAA) and a 10 motif (TGGTTT)
separated by the optimal 17-bp distance (Fig. 1), thus suggest-
ing that blaVEB-1a gene expression is driven by its original
promoter in those Acinetobacter isolates.
This study demonstrates further that blaVEB-like gene ac-
quisition may be linked to a variety of genetic elements (Fig.
2). This is an uncommon observation since the widespread
ESBL genes of the blaTEM, blaSHV, and blaCTX-M types are
usually associated with very conserved genetic structures (28).
In addition, this finding is the first evidence of ISCR2-mediated
acquisition of a -lactamase gene, while ISCR2 has been iden-
tified previously in association with the sul2 sulfonamide resis-
tance gene (26), the dfr18 trimethoprim resistance gene (4, 9),
and the floR florfenicol resistance gene (5, 6). Interestingly, in
the isolates described herein, a fragment larger than the known
blaVEB-1 gene cassette had been mobilized by ISCR2, likely
directly from the bacterial progenitor.
Finally, the origin of this ISCR2 element remains be deter-
mined to better understand where and how the capture of
blaVEB-1a from its natural reservoir has occurred. Although the
blaVEB-1a gene has a GC content of 31.3%, that of ISCR2 is
59.5%, clearly not consistent with the elements’ having the
same origin. ISCR2 has been so far identified in diverse bac-
terial species, including A. baumannii (1).
Nucleotide sequence accession number. The sequences de-
termined in this study have been assigned GenBank accession
number FJ808975.
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